Converge Bio raises $25M Series A to expand its AI drug-discovery platform
TL;DR Converge Bio, a Boston- and Tel Aviv–based startup using generative AI trained on molecular sequences, closed a $25 million…
Wow News on Tech and AI
TL;DR Converge Bio, a Boston- and Tel Aviv–based startup using generative AI trained on molecular sequences, closed a $25 million…